Root Financial Partners’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$252 1141
2026
Q1
$252 Buy
+3
New +$174 ﹤0.01% 3096

Other funds holding DNTH

Root Financial Partners's DNTH Position: Q2 2026 in Review

Root Financial Partners sold out of Dianthus Therapeutics (DNTH) in Q2 2026, closing a stake of 3 shares — an estimated $252 sold.

Root Financial Partners first reported a position in DNTH in Q1 2026 and held it in 1 quarter. The position peaked at $252 in Q1 2026. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Root Financial Partners reported no remaining Dianthus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 3 Dianthus Therapeutics shares in Q2 2026, an estimated $252.
  • Root Financial Partners first reported a position in Dianthus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Dianthus Therapeutics position peaked at $252 in Q1 2026.
  • 269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.